Insider Trading March 26, 2026

Ross Stores Operations President Sells $884,428 in Shares Amid Stock Near 52-Week High

Stephen C. Brinkley disposed of 4,154 shares as the retailer posts strong fiscal results and analysts lift targets

By Leila Farooq ROST
Ross Stores Operations President Sells $884,428 in Shares Amid Stock Near 52-Week High
ROST

Stephen C. Brinkley, President, Operations at Ross Stores, sold 4,154 shares on March 24, 2026, realizing $884,428. The transaction occurred as the stock traded near its 52-week high following a 69% year-over-year gain. Separate company results for fiscal fourth quarter 2025 beat expectations on both earnings and revenue, while several analysts raised price targets.

Key Points

  • Ross Stores President, Operations Stephen C. Brinkley sold 4,154 shares on March 24, 2026, for $212.9101 per share, totaling $884,428.
  • The stock is trading near its 52-week high of $217.51 after a 69% gain over the past year and shows a P/E ratio of 32.3, indicating potential overvaluation relative to Fair Value.
  • Ross Stores beat fourth-quarter fiscal 2025 expectations with EPS of $2.00 and revenue of $6.64 billion; the company opened 17 new stores as it pursues a plan to add about 110 locations by fiscal 2026.

Stephen C. Brinkley, who serves as President, Operations at Ross Stores, INC. (NASDAQ: ROST), executed a sale of 4,154 shares of the company's common stock on March 24, 2026. The shares were sold at a per-share price of $212.9101, producing proceeds of $884,428.

The sale comes at a moment when Ross Stores' shares are trading close to their 52-week high of $217.51, after appreciating roughly 69% over the last 12 months. Analysis indicates the stock currently appears overvalued relative to its Fair Value, with shares trading at a price-to-earnings ratio of 32.3.

Following the disposition, Brinkley holds 64,743 shares of Ross Stores directly.


Company performance and recent developments

Ross Stores reported fiscal fourth-quarter 2025 results that outpaced expectations. The company posted diluted earnings per share of $2.00, above the forecast of $1.88. Revenue for the quarter reached $6.64 billion, exceeding the anticipated $6.38 billion.

Operationally, the retailer opened 17 new stores across February and March, marking the commencement of a larger expansion plan. Management is on track to add approximately 110 new locations by fiscal 2026.


Analyst updates

Several brokerages updated their outlooks for the stock in light of Ross Stores' results and forward guidance. UBS raised its price target to $208 while maintaining a Neutral rating. Bernstein SocGen Group lifted its target to $200, citing strong comparable sales growth, including a 9% increase in fourth-quarter comps. Wells Fargo increased its price target to $235, noting the company has issued historically high guidance for a first-quarter comparable sales increase of 7-8%.


Context for investors

The insider sale coincides with robust operating results and upward revisions from several analysts. At the same time, valuation metrics suggest the stock may be trading above its Fair Value at current levels. The ownership stake retained by the executive is left intact at 64,743 shares after the transaction.

Risks

  • Valuation risk - The stock's P/E ratio of 32.3 suggests shares may be trading above Fair Value, which could affect investor returns in the retail sector.
  • Execution risk on expansion - The plan to open roughly 110 new locations by fiscal 2026 requires successful roll-out of store openings and management of associated costs, affecting retail and real estate exposure.
  • Sales timing risk - Insider selling while shares trade near a 52-week high may raise questions for investors about timing and outlook, impacting market perception in the consumer discretionary sector.

More from Insider Trading

DXP Enterprises Director Sells $697,850 of Stock as Shares Trade Near Yearly Highs Mar 26, 2026 Magnetar Financial Sells 8,840 WHLR Shares for $9,692 as Wheeler REIT Faces Leadership, Capital-Structure Moves Mar 26, 2026 Definium Therapeutics CLO Sells $197,665 in Stock to Cover Tax Withholding Mar 26, 2026 Definium Therapeutics CEO Executes $451K Share Sale; Company Reiterates R&D Focus Mar 26, 2026 Definium Therapeutics CMO Sells Shares to Cover Taxes; Company Reiterates R&D Focus After Q4 2025 Results Mar 26, 2026